Vivos Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $4,054 | $3,419 | $3,248 | $3,301 |
Gross Profit | 2,506 | 1,937 | 1,789 | 1,898 |
EBITDA | -1,791 | -2,157 | -4,135 | -4,788 |
EBIT | -1,936 | -2,303 | -4,284 | -4,938 |
Net Income | -1,930 | -3,763 | -4,259 | -2,093 |
Net Change In Cash | 4,054 | 3,419 | 3,248 | 3,301 |
Free Cash Flow | -3,108 | -2,667 | -2,913 | -2,954 |
Cash | 6,903 | 2,611 | 1,643 | 988 |
Basic Shares | 3,228 | 2,308 | 1,833 | 1,197 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $13,801 | $16,024 | $16,885 | $13,066 |
Gross Profit | 7,650 | 10,019 | 12,604 | 10,412 |
EBITDA | -16,675 | -24,463 | -18,630 | -11,242 |
EBIT | -17,296 | -25,132 | -19,363 | -11,960 |
Net Income | -13,583 | -22,659 | -20,293 | -8,822 |
Net Change In Cash | 13,801 | 16,024 | 16,885 | 13,066 |
Free Cash Flow | -12,799 | -20,511 | -18,131 | -5,800 |
Cash | 1,643 | 3,519 | 24,030 | 18,205 |
Basic Shares | 1,219 | 920 | 849 | 728 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.60 |
2024-03-31 | -$1.63 |
2023-12-31 | -$3.05 |
2023-09-30 | -$1.62 |
